{"id":53309,"date":"2024-11-25T11:33:09","date_gmt":"2024-11-25T11:33:09","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=53309"},"modified":"2024-11-25T11:33:09","modified_gmt":"2024-11-25T11:33:09","slug":"defence-announces-dr-maxime-parisotto-as-cso-director-of-science-and-business-development","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/defence-announces-dr-maxime-parisotto-as-cso-director-of-science-and-business-development\/53309\/","title":{"rendered":"Defence announces Dr Maxime Parisotto as CSO, Director of Science and Business Development"},"content":{"rendered":"
Dr Maxime Parisotto is a seasoned biochemist with over 20 years of experience spanning academic research, drug development, and innovation.<\/p>\n
He holds a PhD in biochemistry focused on breast cancer and metabolism and has held postdoctoral fellowships at prestigious institutions, including the IGBMC in Strasbourg, France, and the Universit\u00e9 de Montr\u00e9al.<\/p>\n
As Senior Analyst, he contributed to significant investment decisions at adMare Bioinnovations. He also holds a graduate certificate in life science entrepreneurship development from Concordia University and will graduate with an MBA from Sherbrooke University in April 2025.<\/p>\n
Dr Parisotto has a robust track record of leadership, including managing multidisciplinary teams and contributing to high-impact scientific publications. Before joining adMare, he led research initiatives in cancer\u00a0biology\u00a0and stem cells at institutions such as the IRCM and Universit\u00e9 de Montr\u00e9al.<\/p>\n
He is an active member of the Canadian biotech ecosystem, with an extensive professional network of contacts and regular participation in national and international conferences.<\/p>\n
His research and business interests focus on advancing drug development from discovery to clinical stages and fostering collaborations between academia, industry, and investors to drive innovation in biopharmaceuticals. His scientific expertise is mainly in oncology, protein biochemistry, cell metabolism, and stem cell\u00a0biology.<\/p>\n